Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma

Condition:   Metastatic Uveal Melanoma Interventions:   Drug: Nivolumab;   Drug: Relatlimab Sponsors:   Jose Lutzky, MD;   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials